News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
119 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21779)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (2286)
August (1969)
Day
2 (21)
3 (134)
4 (182)
5 (180)
6 (174)
7 (76)
9 (47)
10 (146)
11 (152)
12 (92)
13 (139)
14 (94)
16 (32)
17 (75)
18 (119)
19 (87)
20 (105)
21 (26)
23 (16)
24 (72)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
Day
2
3
4
5
6
7
9
10
11
12
13
14
16
17
18
19
20
21
23
24
Opinion
Assessing shared failures with AI is key to cell and gene therapy’s evolution
If we guard our secrets, patients suffer. Only through a commitment to transparency and data sharing—and artificial intelligence—can we make cell and gene therapies safer and more effective.
August 18, 2026
·
5 min read
·
Alexander Seyf
Press Releases
LYNKUET® (elinzanetant) Receives Expanded Market Authorization in Canada for Treatment of Moderate to Severe Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy (AET) Related to Breast Cancer
August 18, 2026
·
8 min read
Press Releases
Definium Therapeutics Announces New Employee Inducement Grants - August 17, 2026
August 18, 2026
·
1 min read
Press Releases
IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group
August 18, 2026
·
3 min read
Press Releases
Amylyx Pharmaceuticals to Announce Topline Results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026
August 18, 2026
·
1 min read
Press Releases
Ionetix Appoints Paul Surdez as Head of Investor Relations
August 18, 2026
·
4 min read
Press Releases
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 17, 2026
August 18, 2026
·
2 min read
Press Releases
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
August 18, 2026
·
8 min read
Press Releases
Enginprime Medical Closes $12M Series A Financing
August 18, 2026
·
3 min read
Press Releases
InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China
August 18, 2026
·
3 min read
1 of 12
Next
